Jaclyn Hechtman, MD

Articles

Dr. Hecht on the Investigation of XL092/Atezolizumab in MSS/MSI-L mCRC

February 1st 2023

J. Randolph (Randy) Hecht, MD, discusses the investigation of XL092 plus atezolizumab in patients with microsatellite stable/microsatellite instability–low metastatic colorectal cancer.

Dr. Hecht on the Symptoms and Diagnosis of ESCC

January 25th 2023

J. Randolph (Randy) Hecht, MD, discusses the common symptoms of esophageal squamous cell carcinoma.

Advice for Providers Treating Metastatic Colorectal Cancer

August 3rd 2022

Experts provide advice for providers treating patients with metastatic colorectal cancer and highlight exciting potential combination treatments on the horizon.

Novel Therapies in HER2-Amplified Metastatic Colorectal Cancer

August 3rd 2022

Dr Andrea Cercek reviews key clinical trials in HER2-amplified colorectal cancer treatment and considers how the approval of new therapies will impact the current treatment landscape.

Treatment Options after Disease Progression in Metastatic Colorectal Cancer

July 22nd 2022

Andrea Cercek, MD, explains the potential treatment options for metastatic colorectal cancer after disease progression.

Individualizing Therapy in HER2+ Metastatic Colorectal Cancer

July 22nd 2022

Dr Jaclyn Hechtman presents the profile of a patient with HER2+ metastatic colorectal cancer and has a conversation with Dr Andrea Cercek on how to personalize frontline therapy selection in each patient.

The Future of Molecular Testing in Colorectal Cancer

July 13th 2022

A look at how the molecular testing landscape in colorectal cancer is evolving.

Challenges and Barriers to Colorectal Cancer Molecular Testing

July 13th 2022

Drs Hechtman and Cercek discuss how practice setting affects molecular testing options and the barriers patients face in receiving testing.

Detecting HER2 Amplification in Colorectal Cancer

July 6th 2022

Experts describe which patients should be screened for HER2 amplification in colorectal cancer and how best to detect it.

Molecular Testing Options in Colorectal Cancer

July 6th 2022

A pathologist explains how she chooses between a variety of molecular testing technology options in colorectal cancer.

Overview of Molecular Testing in Colorectal Cancer

June 15th 2022

Jaclyn Hechtman, MD, provides an overview of the history of molecular testing in colorectal cancer and how testing has evolved.